Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This clinical trial aims to see if patients with triple negative breast cancer can complete a biobehavioral stress reduction program that also addresses health related social needs (e.g., utilities, transportation, etc.). The stress reduction program is over ten weeks and includes stress reduction (e.g., progressive muscle relaxation), coping, problem solving, communication, and social support. Health related social needs will be evaluated at the beginning of the study, and referrals will be made to social work to help address those needs. The study will examine stress as reported by the patients and also use biological markers.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Osoby w wieku 18 lat lub starsze
- •Nowo zdiagnozowany, nieleczony potrójnie ujemny rak piersi
- •Rak we wczesnym stadium (stadia I-III)
✗ Disqualifies
- •Więźniowie
- •Mężczyźni
- •Osoby nie mówiące i nie rozumiejące języka angielskiego
- •Osoby z rozpoznanym wcześniej rakiem piersi (w tym in situ)
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- June 29, 2026
- Sex
- Female only
Therapies / drugs in trial
Locations (2)
MetroHealth
Cleveland, United States
Ohio State University Comprehensive Cancer Center
Columbus, United States
Trial contact
The Ohio State Comprehensive Cancer Center
Contact information from ClinicalTrials.gov. Contact in English.
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/3/2026.